We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.35B
AUM Growth
+$25.5M
Cap. Flow
+$32.7M
Cap. Flow %
2.42%
Top 10 Hldgs %
12.05%
Holding
2,121
New
584
Increased
441
Reduced
528
Closed
563

Top Sells

Rank Stock Value
1
LMND icon
Lemonade
LMND
+$4.64M
2
MGNI icon
Magnite
MGNI
+$3.66M
3
RELY icon
Remitly
RELY
+$3.66M
4
MNRO icon
Monro
MNRO
+$3.65M
5
VGR
Vector Group Ltd.
VGR
+$3.32M

Sector Composition

Rank Sector Weight
1 Technology 16.19%
2 Healthcare 13.13%
3 Financials 12.64%
4 Consumer Discretionary 12.16%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GENI icon
1401
Genius Sports
GENI
$2.11B
$205K 0.02%
23,727
-44,135
-65% -$368K
IVVD icon
1402
Invivyd
IVVD
$218M
$205K 0.02%
+462,438
New +$360K
LCTX icon
1403
Lineage Cell Therapeutics
LCTX
$278M
$205K 0.02%
408,837
+315,805
+339% +$232K
GPK icon
1404
Graphic Packaging
GPK
$3.58B
$204K 0.02%
7,517
-1,625
-18% -$47K
ROCK icon
1405
Gibraltar Industries
ROCK
$1.49B
$204K 0.02%
+3,466
New +$236K
TER icon
1406
Teradyne
TER
$59.3B
$204K 0.02%
+1,619
New +$192K
KOP icon
1407
Koppers
KOP
$969M
$203K 0.02%
+6,272
New +$224K
RH icon
1408
RH
RH
$3.71B
$203K 0.02%
515
-416
-45% -$148K
KDP icon
1409
Keurig Dr Pepper
KDP
$40.8B
$202K 0.02%
6,303
-14,451
-70% -$489K
KN icon
1410
Knowles
KN
$3.34B
$202K 0.02%
+10,116
New +$188K
LGIH icon
1411
LGI Homes
LGIH
$1.4B
$202K 0.02%
2,260
-1,905
-46% -$200K
MNSB icon
1412
MainStreet Bancshares
MNSB
$172M
$202K 0.02%
11,165
-9,984
-47% -$183K
MUSA icon
1413
Murphy USA
MUSA
$9.61B
$202K 0.02%
+403
New +$206K
NUS icon
1414
Nu Skin
NUS
$267M
$202K 0.02%
29,254
-64,373
-69% -$443K
PH icon
1415
Parker-Hannifin
PH
$135B
$202K 0.02%
317
-742
-70% -$491K
GRVY
1416
GRAVITY
GRVY
$473M
$201K 0.01%
3,180
-1,021
-24% -$65.5K
KXI icon
1417
iShares Global Consumer Staples ETF
KXI
$1.07B
$201K 0.01%
3,332
VMD icon
1418
Viemed Healthcare
VMD
$371M
$201K 0.01%
25,060
+7,224
+41% +$62.7K
OBDE
1419
DELISTED
Blue Owl Capital Corporation III
OBDE
$197K 0.01%
+13,630
New +$201K
NEWT icon
1420
NewtekOne
NEWT
$391M
$196K 0.01%
+15,373
New +$209K
AVNS
1421
DELISTED
Avanos Medical
AVNS
$193K 0.01%
+12,114
New +$240K
CRVS icon
1422
Corvus Pharmaceuticals
CRVS
$1.17B
$193K 0.01%
+36,096
New +$269K
LDI icon
1423
loanDepot
LDI
$516M
$193K 0.01%
94,401
-73,177
-44% -$163K
PLTK icon
1424
Playtika
PLTK
$1.12B
$193K 0.01%
+27,759
New +$219K
ANIK icon
1425
Anika Therapeutics
ANIK
$287M
$191K 0.01%
11,576
-19,899
-63% -$392K

Similar funds

GSA Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, GSA Capital Partners held 2,121 positions worth $1.35B, up 1.9% from $1.32B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners's Q4 2024 filing shows 584 new, 441 increased, 528 reduced and 563 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M. The largest sale was Lemonade, an estimated $4.64M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • GSA Capital Partners's largest Q4 2024 buy was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M.
  • GSA Capital Partners added most to Frontline in Q4 2024, an estimated $5.7M increase.
  • GSA Capital Partners's biggest Q4 2024 reduction was Lemonade, cutting an estimated $4.64M.
  • GSA Capital Partners fully exited Monro in Q4 2024, selling an estimated $3.65M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.35B portfolio in Q4 2024.
  • GSA Capital Partners opened 584 new positions and closed 563 in Q4 2024.
  • GSA Capital Partners's portfolio value rose 1.9% quarter-over-quarter to $1.35B.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.